Organoids

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

How automation and AI enable reliable, scalable models

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

Antibody drug conjugate
#Antibody drug conjugate (ADC) #Drug discovery #Organoids

Factsheet: Discover how organoids are advancing ADC research

Unlock insights into ADC development with HUB Organoids’ new factsheet on patient-derived organoids, available to download now. Discover how advanced 3D tumour models are transforming preclinical testing and supporting safer, more effective antibody-drug conjugates. What you’ll learn: How organoids outperform traditional preclinical models for ADCs Strategies for evaluating efficacy,… Read More

#News

#Antibody drug conjugate (ADC) #Drug discovery #Organoids

Advance Your ADC Research – Organoids Vs. Traditional Models

Unlock insights into ADC development with HUB Organoids’ factsheet on patient-derived organoids. Discover how advanced 3D tumour models are transforming preclinical testing and supporting safer, more effective antibody-drug conjugates. What you’ll learn: How organoids outperform traditional preclinical models for ADCs Strategies for evaluating efficacy, safety, and biomarker discovery Real-world case… Read More

#Resources

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Standardising organoid workflows: How automation and AI enable reliable, scalable models

Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow challenges, from culture variability to labour-intensive handling. This webinar, hosted by DDW and supported by Galatek, explores the evolving landscape of organoid research, identify common bottlenecks in daily… Read More

Webinar date:
Supported by Galatek
#Webinars

Organoid
#Disease modelling #National Institutes of Health (NIH) #New approach methodologies (NAMs) #Organoids

First-of-its-kind organoid centre to reduce reliance on animal models

A new US Standardized Organoid Modeling (SOM) Center will be dedicated to using cutting-edge technologies to develop standardised organoid-based new approach methodologies (NAMs).   With contracts totalling $87 million for the first three years, the centre will be housed at the Frederick National Laboratory for Cancer Research (FNLCR),… Read More

#News

#Drug discovery #Financing #Non-animal model (NAM) #Organoids #Parallel Bio

Parallel Bio secures $21m to advance human-first drug discovery

Biotech company Parallel Bio has raised $21 million in a Series A funding led by AIX Ventures.   The round attracted new investors Amplo and Marc Benioff, founder and CEO of Salesforce, and existing investors Metaplanet, Humba Ventures, Atypical Ventures, Undeterred Capital, and Jeff Dean.   Robert DiFazio, CEO and Co-Founder at… Read More

#Business & Investment #News

X-ray showing colon cancer
#Bowel cancer #Drug resistance #Oncology #Organoids #The Institute of Cancer Research

Scientists uncover mechanism behind drug resistance in bowel cancer

Scientists at The Institute of Cancer Research (ICR), London, have discovered what may cause some treatments to stop working in people living with bowel cancer.   The findings could help researchers use information about a person’s cancer to make better use of current treatments and develop more targeted… Read More

#Cancer Research #News

#3D cell culture #Cell Science #Drug discovery #Organoids #Stem cells

Pushing drug discovery with stem cells, organoids and 3D cell cultures

DDW Editor Reece Armstrong looks at how advances in stem cells, organoids and 3D cell cultures are affecting drug discovery and development.  Stem cells, organoids and 3D cell cultures have emerged as promising tools that scientists can use to better understand disease and how drugs function within the human body. … Read More

#Exclusive Content

Virus and antibodies
#Cell Science #In Focus Report #Market reporting #Organoids

Explore our latest eReport: 3D biology and organoids

Organoids and 3D biology are revolutionising drug discovery, offering more physiologically relevant models to study diseases, screen compounds, and develop personalised treatments. These technologies provide deeper insights into human biology, bridging the gap between in vitro research and clinical success.  In 2024, the field has seen significant… Read More

#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

New webinar showcases cutting-edge tools for drug discovery

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

Human cell
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Register now: Discover a robust method for organoid development

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Webinar: Complex in vitro models and AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

Pluripotent stem cells
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Webinar: Generate human hepatic organoids from iPSCs

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Combining complex in vitro models with AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

Stem cells
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells #Webinar

Webinar: Differentiate iPSCs into hepatic lineage cells and organoids

The value of stem cells in laboratory and clinical research has been clearly demonstrated through numerous studies, showcasing their potential as models for a wide range of diseases and therapeutic developments. The inherent flexibility of stem cells allows for the development of various tissue types from a single,… Read More

Webinar date:
Supported by Sartorius
#News